[Experimental study of the antimicrobial properties and antineoplastic effect of the new pentaenic antibiotic 661].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D001230:Aspergillus / Q000187:drug effects; D001409:Bacillus cereus / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002175:Candida / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D002460:Cell Line; D046508:Culture Techniques; D003864:Depression, Chemical; D004926:Escherichia coli / Q000187:drug effects; D056890:Eukaryota / Q000187:drug effects*; D005658:Fungi / Q000187:drug effects*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012440:Saccharomyces / Q000187:drug effects; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects
D000903:Antibiotics, Antineoplastic
Izuchenie v éksperimente antimikrobnykh svoĭstv i protivoopukholevoĭ aktivnosti novogo pentaenovogo antibiotika 661.